The National Institutes of Health is shaking up its process for soliciting research ideas and awarding grants to scientists.

Patients taking Pfizer’s Vyndaqel and Vyndamax for a progressive, often fatal form of heart failure will not see cheaper ...

Bill Glod surveys Matt Zwolinski and Miranda Perry Fleischer’s defense of a universal basic income that would replace most ...

Centers for Medicare & Medicaid Services said on Wednesday it has extended key application ‌deadlines for drugmakers and ...

Key Takeaways CMS’ Innovation Center is accelerating new payment and care delivery models as the Trump administration uses ...

The risk for Oracle is that it may be sinking a lot of money into building data centers for OpenAI, only for OpenAI to be ...

First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025Dupixent® global net sales(recorded by Sanofi) increased 33% ...

For an accessible version of this Press Release, please visit Q1 2026 revenues of ~$4.0 billion increased by 2% in U.S.

Refer to the "Footnotes" section included herein for further explanation of disclosures for Adjusted (non-GAAP) financial measures, as well as additional reconciliations. Humana will host a live ...

First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025Dupixent- global net sales (recorded by Sanofi) increased 33% to $4.9 billion EYLEA HD- U.S. net sales increased 52% ...